Dr. Reddy’s Laboratories announces launch of Tetrabenazine Tablets in U.S. Market
MediaInfoline
Feb 02
Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it has launchedTetrabenazine Tablets, a therapeutic equivalent generic version of Xenazine® (tetrabenazine) in the United States market approved by the U.S. Food and ...
